Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q40657351)
Watch
English
High dose chemotherapy with autologous stem cell support for the treatment of metastatic breast cancer.
scientific article published on July 1994
In more languages
default for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
8004629
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8004629%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 October 2019
review article
1 reference
stated in
Europe PubMed Central
title
High dose chemotherapy with autologous stem cell support for the treatment of metastatic breast cancer
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
8004629
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8004629%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 October 2019
main subject
metastatic breast cancer
1 reference
based on heuristic
inferred from title
author name string
L J Ayash
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
8004629
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8004629%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 October 2019
language of work or name
English
0 references
publication date
1 July 1994
1 reference
stated in
Europe PubMed Central
PubMed publication ID
8004629
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8004629%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 October 2019
published in
Cancer
1 reference
stated in
Europe PubMed Central
PubMed publication ID
8004629
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8004629%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 October 2019
volume
74
1 reference
stated in
Europe PubMed Central
PubMed publication ID
8004629
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8004629%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 October 2019
issue
1 Suppl
1 reference
stated in
Europe PubMed Central
PubMed publication ID
8004629
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8004629%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 October 2019
page(s)
532-535
1 reference
stated in
Europe PubMed Central
PubMed publication ID
8004629
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8004629%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 October 2019
cites work
Pathologic findings from the National Surgical Adjuvant Project for Breast Cancers (protocol no. 4). X. Discriminants for tenth year treatment failure
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.2820741343
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Diverse prognosis in metastatic breast cancer: who should be offered alternative initial therapies?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.2820741343
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Alkylating agent resistance: in vitro studies with human cell lines
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.2820741343
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Increasing the therapeutic response rates to anticancer drugs by applying the basic principles of pharmacology
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.2820741343
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High-dose combination alkylating agent chemotherapy with autologous bone marrow support for metastatic breast cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.2820741343
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.2820741343
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cyclophosphamide and thiotepa with autologous bone marrow transplantation in patients with solid tumors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.2820741343
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase I-II study of cyclophosphamide, thiotepa, and carboplatin with autologous bone marrow transplantation in solid tumor patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.2820741343
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cisplatin as first-line therapy for metastatic breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.2820741343
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase I-II study of bialkylator chemotherapy, high-dose thiotepa, and cyclophosphamide with autologous bone marrow reinfusion in patients with advanced cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.2820741343
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.2820741343
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High-dose consolidation therapy with autologous stem-cell rescue in stage IV breast cancer: follow-up report
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.2820741343
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of estrogen receptor-negative or hormonally refractory breast cancer with double high-dose chemotherapy intensification and bone marrow support
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.2820741343
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.2820741343
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1002/CNCR.2820741343
1 reference
stated in
Europe PubMed Central
PubMed publication ID
8004629
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8004629%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 October 2019
PubMed publication ID
8004629
1 reference
stated in
Europe PubMed Central
PubMed publication ID
8004629
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8004629%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 October 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
